The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. (December 2013)
- Record Type:
- Journal Article
- Title:
- The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy. (December 2013)
- Main Title:
- The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy
- Authors:
- Thanigaimani, K.
Mohamed, F.
Cecil, T.
Moran, B. J.
Bell, J. - Abstract:
- <abstract abstract-type="main" id="codi12444-abs-0001"> <title>Abstract</title> <sec id="codi12444-sec-0001" sec-type="section"> <title>Aim</title> <p>The optimal strategy for intravenous (IV) fluid management during administration of hyperthermic intraperitoneal chemotherapy (HIPEC) is unclear. In this prospective study we describe the use of a LiDCO<italic>rapid</italic>™ (LiDCO, Cambridge, UK) cardiac output monitor to guide IV fluid management during cytoreductive surgery (CRS) with HIPEC. The aim of this study was to determine whether cardiac output monitoring will allow close maintenance of physiological parameters during the HIPEC phase.</p> </sec> <sec id="codi12444-sec-0002" sec-type="section"> <title>Method</title> <p>Twenty‐five patients who underwent CRS combined with HIPEC were included in the study. Intra‐operative IV fluid boluses were titrated using parameters measured by the LiDCO<italic>rapid</italic>™ monitor. Stroke volume variation was maintained below 10% with fluid boluses and mean arterial pressure was maintained within 20% of the baseline figure with vasopressors.</p> </sec> <sec id="codi12444-sec-0003" sec-type="section"> <title>Results</title> <p>There was no significant change in heart rate and cardiac output. The systemic vascular resistance dropped from an average of 966 dyn.s/cm‐5 to 797 dyn s/cm<sup>5</sup> at 60 min during the HIPEC phase (<italic>P </italic>=<italic> </italic>0.62) despite an increase in the dose of phenylepherine. The<abstract abstract-type="main" id="codi12444-abs-0001"> <title>Abstract</title> <sec id="codi12444-sec-0001" sec-type="section"> <title>Aim</title> <p>The optimal strategy for intravenous (IV) fluid management during administration of hyperthermic intraperitoneal chemotherapy (HIPEC) is unclear. In this prospective study we describe the use of a LiDCO<italic>rapid</italic>™ (LiDCO, Cambridge, UK) cardiac output monitor to guide IV fluid management during cytoreductive surgery (CRS) with HIPEC. The aim of this study was to determine whether cardiac output monitoring will allow close maintenance of physiological parameters during the HIPEC phase.</p> </sec> <sec id="codi12444-sec-0002" sec-type="section"> <title>Method</title> <p>Twenty‐five patients who underwent CRS combined with HIPEC were included in the study. Intra‐operative IV fluid boluses were titrated using parameters measured by the LiDCO<italic>rapid</italic>™ monitor. Stroke volume variation was maintained below 10% with fluid boluses and mean arterial pressure was maintained within 20% of the baseline figure with vasopressors.</p> </sec> <sec id="codi12444-sec-0003" sec-type="section"> <title>Results</title> <p>There was no significant change in heart rate and cardiac output. The systemic vascular resistance dropped from an average of 966 dyn.s/cm‐5 to 797 dyn s/cm<sup>5</sup> at 60 min during the HIPEC phase (<italic>P </italic>=<italic> </italic>0.62) despite an increase in the dose of phenylepherine. The average total volume of fluid given was 748 ml in the first 30 min and 630 ml in the second 30 min with an average urine output of 307 and 445 ml, respectively. The change in lactate levels was not statistically or clinically significant.</p> </sec> <sec id="codi12444-sec-0004" sec-type="section"> <title>Conclusion</title> <p>LiDCO<italic>rapid</italic>™ is an effective noninvasive tool for guiding fluid management in this population. It allows the anaesthesiologist to maintain tight control of essential physiological parameters during a phase of the procedure in which there is a risk of renal injury.</p> </sec> </abstract> … (more)
- Is Part Of:
- Colorectal disease. Volume 15:Number 12(2013)
- Journal:
- Colorectal disease
- Issue:
- Volume 15:Number 12(2013)
- Issue Display:
- Volume 15, Issue 12 (2013)
- Year:
- 2013
- Volume:
- 15
- Issue:
- 12
- Issue Sort Value:
- 2013-0015-0012-0000
- Page Start:
- 1537
- Page End:
- 1542
- Publication Date:
- 2013-12
- Subjects:
- Colon (Anatomy) -- Diseases -- Periodicals
Rectum -- Diseases -- Periodicals
616.34 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cdi ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/codi.12444 ↗
- Languages:
- English
- ISSNs:
- 1462-8910
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3322.110000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3830.xml